Clinical risk factors for vasculo-placental disorders: results from a prospective case-control study nested in HEMOTHEPP French cohort study.
暂无分享,去创建一个
L. Gourhant | C. de Moreuil | F. Couturaud | E. Nowak | P. Dupré | P. Merviel | E. Moigne | Catherine A Lemarié | C. Trémouilhac | B. P. Petesch | F. Anouilh | Sara Robin | Charles Bellot | G. Drugmanne | M. Müller | Julien Coadic | Line Bihan | C. de Moreuil | Lenaick Gourhant | Catherine A. Lemarié
[1] S. Maguire,et al. Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis. , 2020, Seminars in arthritis and rheumatism.
[2] E. Carreras,et al. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial , 2020, Fetal Diagnosis and Therapy.
[3] C. D. de Groot,et al. Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism , 2020, Hypertension.
[4] K. Bennett,et al. Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population , 2019, Journal of thrombosis and haemostasis : JTH.
[5] I. Pantic,et al. The association between IUGR and maternal inherited thrombophilias , 2018, Medicine.
[6] N. Uldbjerg,et al. Tinzaparin for the treatment of foetal growth retardation: An open-labelled randomized clinical trial. , 2018, Thrombosis research.
[7] A. David,et al. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction. , 2017, American journal of obstetrics and gynecology.
[8] A. Fauchais,et al. [Pre-eclampsia prevention in 2018 in general population and in lupic women: At the dawn of a personalized medicine?] , 2018, La Revue de medecine interne.
[9] E. Polard,et al. [Aspirin: Indications and use during pregnancy]. , 2017, La Revue de medecine interne.
[10] K. Aagaard,et al. Impact of USPSTF recommendations for aspirin for prevention of recurrent preeclampsia , 2017, American journal of obstetrics and gynecology.
[11] Nicola Persico,et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia , 2017, The New England journal of medicine.
[12] S. Kane,et al. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial , 2017, American journal of obstetrics and gynecology.
[13] K. Nicolaides,et al. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.
[14] J. Gris,et al. Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial , 2016, Obstetrics and gynecology.
[15] P. Robillard,et al. Pre-eclampsia and preterm birth in Reunion Island: a 13 years cohort-based study. Comparison with international data , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[16] L. Novack,et al. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia , 2016, Thrombosis and Haemostasis.
[17] C. Abheiden,et al. Does low‐molecular‐weight heparin influence fetal growth or uterine and umbilical arterial Doppler in women with a history of early‐onset uteroplacental insufficiency and an inheritable thrombophilia? Secondary randomised controlled trial results , 2016, BJOG : an international journal of obstetrics and gynaecology.
[18] G. Maruotti,et al. Diagnosis of placental abruption: a legal issue for physicians , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[19] J. Blacher,et al. [Hypertension and pregnancy. Expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology]. , 2016, Presse medicale.
[20] C. Flamant,et al. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. , 2015, European journal of obstetrics, gynecology, and reproductive biology.
[21] E. Horváth-Puhó,et al. Preconception venous thromboembolism and placenta‐mediated pregnancy complications , 2015, Journal of thrombosis and haemostasis : JTH.
[22] N. Smith,et al. Association Between Newborn Birth Weight and the Risk of Postpartum Maternal Venous Thromboembolism: A Population-Based Case–Control Study , 2015, Circulation.
[23] J. Douketis,et al. Factors that predict thrombosis in relatives of patients with venous thromboembolism. , 2014, Blood.
[24] F. Granath,et al. Birth Outcomes in Women with Inflammatory Bowel Disease: Effects of Disease Activity and Drug Exposure , 2014, Inflammatory bowel diseases.
[25] A. Shennan,et al. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. , 2015, Obstetrics and gynecology.
[26] A. Gaudineau. [Prevalence, risk factors, maternal and fetal morbidity and mortality of intrauterine growth restriction and small-for-gestational age]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.
[27] J. Sundquist,et al. Venous thromboembolism does not share strong familial susceptibility with pre‐eclampsia/eclampsia: a nationwide family study in Sweden , 2013, BJOG : an international journal of obstetrics and gynaecology.
[28] A. Ego. [Definitions: small for gestational age and intrauterine growth retardation]. , 2013, Journal de gynecologie, obstetrique et biologie de la reproduction.
[29] M. Petri,et al. Management of pregnancy in systemic lupus erythematosus , 2012, Nature Reviews Rheumatology.
[30] P. Mortensen. EPIDEMIOLOGY , 2012, Schizophrenia Research.
[31] E. Ferrazzi,et al. Recurrence and severity of abnormal pregnancy outcome in patients treated by low-molecular-weight heparin: a prospective pilot study , 2012, Journal of Maternal-Fetal & Neonatal Medicine.
[32] G. Leone,et al. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband , 2011, Thrombosis and Haemostasis.
[33] A. Many,et al. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia , 2011, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[34] C. Gordon,et al. Managing pregnancy in inflammatory rheumatological diseases , 2011, Arthritis research & therapy.
[35] G. Hoff,et al. Risk factors for recurrent small-for-gestational-age birth. , 2010, American journal of perinatology.
[36] K. Haram,et al. The HELLP syndrome: Clinical issues and management. A Review , 2009, BMC pregnancy and childbirth.
[37] J. Dungan. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data , 2008 .
[38] P. Langhorne,et al. Thrombophilia in pregnancy: a systematic review , 2006, British journal of haematology.
[39] Kirsten Duckitt,et al. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies , 2005, BMJ : British Medical Journal.
[40] M. Rodger,et al. A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction. , 2005, American journal of obstetrics and gynecology.
[41] Yun-fei Gao,et al. [Effect of heparin on fetal growth restriction]. , 2004, Zhonghua fu chan ke za zhi.
[42] T. Leet,et al. Body Mass Index Change Between Pregnancies and Small for Gestational Age Births , 2004, Obstetrics and gynecology.
[43] H. Honest,et al. Aspirin for Prevention of Preeclampsia in Women With Historical Risk Factors: A Systematic Review , 2003, Obstetrics and gynecology.
[44] D. Roberts,et al. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. , 2002, European journal of obstetrics, gynecology, and reproductive biology.
[45] A. Many,et al. Pathologic Features of the Placenta in Women With Severe Pregnancy Complications and Thrombophilia , 2001, Obstetrics and gynecology.
[46] A. Kaider,et al. Preeclampsia and Fetal Loss in Women With a History of Venous Thromboembolism , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[47] F. Kraus,et al. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. , 1999, Human pathology.
[48] J N Martin,et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. , 1999, American journal of obstetrics and gynecology.
[49] O. Thorarensen,et al. Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis , 1997, Annals of neurology.
[50] K. Ward,et al. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction. , 1997, American journal of obstetrics and gynecology.